Aspirin DL-lysine
CAS No. | 62952-06-1 | Cat. No. | BCP12010 |
Name | Aspirin DL-lysine | ||
Synonyms | DL-Lysine acetylsalicylate; Lysine acetylsalicylate; | ||
Formula | C9H8O4.C6H14N2O2;C15H22N2O6 | M. Wt | 326.35 |
Description | Aspirin DL-Lysine is the lysine salt form of acetylsalicylic acid, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic and anti-inflammatory activities. Like other NSAIDs, aspirin DL-lysine inhibits the activity of cyclooxygenase I and II, resulting in decreased formation of prostaglandins (PGs) and thromboxanes precursors. This leads to decreased PG synthesis by PG synthase. This agent also causes a decrease in the formation of thromboxane A2 synthesis by thromboxane synthase, thereby inhibiting platelet aggregation. | ||
Pathways | Neuro Signaling Pathway | ||
Targets | COX |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.